Abstract:Acute myeloid leukemia (AML) is caused by the abnormal proliferation and differentiation of a clonal population of myeloid progenitors. EBF1 is a key transcriptional factor in regulating hematopoiesis and has been linked to acute lymphoblastic leukemia (ALL). However, the relationship between AML and EBF1 mutation has not yet been studied. Recent research has shown that deleting EBF1 results in myeloid-biased progenitors and decreased HSC quiescence and repopulation capacity. This suggests that EBF1 is involved in earlier hematopoiesis and has additional functions beyond B-cell committed development. Our clinical center conducted whole-exome sequencing on 231 cases of acute myeloid leukemia and identified four patients with an Ebf1 mutation. This corresponds to a mutation frequency of 1.73% and the mutations were identified as p.Q477H (c.1434G>T), p.S513P (c.1537T>C), p.C534F (c.1601GT), and p.P570A (c.1708C>G). Data from the cBioPortal database showed that AML patients with Ebf1 deep deleted mutation had shortened survival. To better understand the role of Ebf1 in AML pathogenesis, we generated an ebf1a-deficient zebrafish mutant. Further research showed that the ebf1a deficiency caused neutrophilia during primitive hematopoiesis. BrdU staining in Tg(coronin1a: GFP) labeled myeloid progenitors was significantly higher in ebf1a-deficient larvae than in wild-type larvae, indicating that ebf1a deficiency led to increased proliferating myeloid progenitors which would take responsibility for the neutrophilia in early-developing larvae. We conducted experiments using four RNA variants (p.Q477H, p.S513P, p.C534F, and p.P570A) injected into ebf1a deficiency zebrafish larvae to verify their pathogenicity. Our findings showed that while EBF1 p.Q477H and p.S513P caused a decrease in neutrophils, p.C534F resulted in neutrophilia, indicating that it might be a loss-of-function mutation. To further understand the mechanism, we introduced EBF1 p.C534F to AML cell culture, and CCk8 and cell cycle analysis showed increased proliferation rates and disturbed cell cycle balance, leading to increased proliferation of AML cells of EBF1-C534F mutation. The cells bearing this mutation showed a higher rate of proliferation, likely due to a disturbance in the balance of the cell cycle. These findings provide valuable insight into the potential pathogenetic mechanism of EBF1 p.C534F. Our investigation into the cause of ebf1 deficiency disrupting normal hematopoiesis led us to perform bulk RNA-sequencing with sorted myeloid-progenitors labeled by Tg:(coronin1a-GFP) in 30hpf zebrafish larvae. We found that leukocyte differentiation and myeloid cell cycle-related genes such as lyz, lygl1, coro1a, lcp1, cebpa, spi1b, mpx, irf8, il6, il34, etc were upregulated in ebf1a deficiency zebrafish. Additionally, anxa1c, anxa1b, Cish, and nlrc3l, which have been reported to suppress lymphoid proliferation but increase myeloid expansion, were down-regulated. Go enrichment analysis showed that the significant genes were associated with hematopoietic disorders including AML and MDS. To address the issue of disturbed cell cycle balance caused by EBF1 deficiency and loss-of-function mutation, we sought to suppress the G1-S transition via CDK inhibitor. We treated EBF1-C534F, EBF1-WT, and control AML cell culture with CDK4 inhibitor: AMG925. We were surprised to find that the CDK4 inhibitor sufficiently suppressed the proliferation and reversed the prolonged S phase caused by EBF1 mutation. We investigated the myeloid-bias function of Ebf1 deficiency and the potential pathogenesis of EBF1 mutations of AML from the development view and were surprised to find CDK inhibitors as a potential drug for EBF1-deficient AML patients.

A CHAF1B-Dependent Molecular Switch in Hematopoiesis and Leukemia Pathogenesis

Forced Over-Expression of the Myeloid Zinc Finger Gene MZF-1 Inhibits Apoptosis and Promotes Oncogenesis in Interleukin-3-dependent FDCP.1 Cells.

CHAF1B Overexpression: A Brake for the Differentiation of Leukemia Cells

A Distinct Epigenetic Signature at Targets of a Leukemia Protein

The Chromatin Remodeling Subunit Baf200 Promotes Normal Hematopoiesis and Inhibits Leukemogenesis.

CHAF1b, chromatin assembly factor-1 subunit b, is essential for mouse preimplantation embryos

Histone chaperone ASF1A accelerates chronic myeloid leukemia blast crisis by activating Notch signaling

JMJD3 Facilitates C/EBPβ-centered Transcriptional Program to Exert Oncorepressor Activity in AML

CTCF Boundary Remodels Chromatin Domain and Drives Aberrant HOX Gene Transcription in Acute Myeloid Leukemia.

Chd7 deficiency delays leukemogenesis in mice induced by Cbfb-MYH11

Baf155 controls hematopoietic differentiation and regeneration through chromatin priming

Haematopoietic Malignancies Caused by Dysregulation of a Chromatin-Binding PHD Finger

CBFβ-SMMHC, Expressed in M4Eo AML, Reduced CBF DNA-binding and Inhibited the G1 to S Cell Cycle Transition at the Restriction Point in Myeloid and Lymphoid Cells

Leukemia-mutated proteins PHF6 and PHIP form a chromatin complex that represses acute myeloid leukemia stemness

Bahcc1 is critical for the aberrant epigenetic program in a mouse model of MLL-ENL- mediated leukemia

Exploring the contribution of Zfp521/ZNF521 on primary hematopoietic stem/progenitor cells and leukemia progression

Chromatin remodeler CHD8 governs hematopoietic stem/progenitor survival by regulating ATM-mediated P53 protein stability

A mutant ASXL1-EHMT complex contributes to heterochromatin dysfunction in clonal hematopoiesis and chronic monomyelocytic leukemia

Chromatin Assembly Factor 1 (CAF-1) facilitates the establishment of facultative heterochromatin during pluripotency exit

Ebf1 is Involved in Primitive Myelopoiesis and Contributes in Leukemia Pathogenesis

The TLK-ASF1 histone chaperone pathway plays a critical role in IL-1b-mediated AML progression